Candriam S.C.A. Agenus Inc Transaction History

Candriam S.C.A.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2018 Aug 14, 2018	SELL	$2.26 - $4.65 $836,199 - $1.72 Million	-370,000 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$3.51 - $6.04 $1 Million - $1.72 Million	-285,000 Reduced 43.51%	370,000 $1.74 Million
Q4 2017 Feb 07, 2018	BUY	$3.26 - $4.78 $121,597 - $178,294	37,300 Added 6.04%	655,000 $2.14 Million
Q3 2017 Nov 03, 2017	BUY	$3.48 - $4.44 $2.15 Million - $2.74 Million	617,700	617,700 $2.72 Million

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Candriam S.C.A., based on Form 13F filings with the SEC.

Stay updated on Candriam S.C.A. with notifications on news.